|
Volumn 28, Issue SUPPL. 64, 2001, Pages 60-61
|
The status of stem cell transplantation for rheumatoid arthritis: A rheumatologist's view
|
Author keywords
Patient selection; Regimen selection; Rheumatoid arthritis; Stem cell transplantation
|
Indexed keywords
ANTIRHEUMATIC AGENT;
CYCLOPHOSPHAMIDE;
TUMOR NECROSIS FACTOR ANTIBODY;
CELL INFILTRATION;
CONFERENCE PAPER;
DISEASE ACTIVITY;
DISEASE SEVERITY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
PATIENT SELECTION;
PRIORITY JOURNAL;
REMISSION;
RHEUMATOID ARTHRITIS;
CLINICAL PROTOCOL;
HOSPITALIZATION;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
RHEUMATOLOGY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ARTHRITIS, RHEUMATOID;
CLINICAL PROTOCOLS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MULTICENTER STUDIES;
PATIENT SELECTION;
RHEUMATOLOGY;
SEVERITY OF ILLNESS INDEX;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 0034790736
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (6)
|